BELLINI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 13.796
AS - Asia 7.359
EU - Europa 5.234
SA - Sud America 1.246
Continente sconosciuto - Info sul continente non disponibili 530
AF - Africa 523
OC - Oceania 27
Totale 28.715
Nazione #
US - Stati Uniti d'America 13.410
SG - Singapore 2.396
CN - Cina 2.005
IT - Italia 1.881
HK - Hong Kong 1.148
BR - Brasile 1.027
SE - Svezia 713
VN - Vietnam 632
DE - Germania 497
BG - Bulgaria 367
GB - Regno Unito 357
FR - Francia 300
KR - Corea 277
CA - Canada 276
FI - Finlandia 260
RU - Federazione Russa 217
CD - Congo 206
TR - Turchia 190
UA - Ucraina 155
IN - India 151
JP - Giappone 130
AT - Austria 116
CI - Costa d'Avorio 94
BD - Bangladesh 85
AR - Argentina 73
CH - Svizzera 70
NL - Olanda 65
MX - Messico 56
IQ - Iraq 51
PL - Polonia 51
ES - Italia 49
ZA - Sudafrica 41
MA - Marocco 40
ID - Indonesia 37
NG - Nigeria 32
EC - Ecuador 31
CO - Colombia 30
PK - Pakistan 30
BE - Belgio 29
MY - Malesia 28
SA - Arabia Saudita 26
UZ - Uzbekistan 26
AU - Australia 25
SN - Senegal 24
EG - Egitto 21
VE - Venezuela 19
IR - Iran 18
CL - Cile 17
PH - Filippine 16
KE - Kenya 15
PE - Perù 15
PT - Portogallo 15
JO - Giordania 14
PY - Paraguay 14
DZ - Algeria 13
GR - Grecia 13
IL - Israele 13
NO - Norvegia 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
IE - Irlanda 11
TH - Thailandia 11
UY - Uruguay 11
CZ - Repubblica Ceca 10
LT - Lituania 10
JM - Giamaica 9
NP - Nepal 9
TT - Trinidad e Tobago 9
LB - Libano 8
PS - Palestinian Territory 8
ET - Etiopia 7
NI - Nicaragua 7
TW - Taiwan 7
AZ - Azerbaigian 6
BO - Bolivia 6
AL - Albania 5
CR - Costa Rica 5
HN - Honduras 5
PA - Panama 5
BJ - Benin 4
DK - Danimarca 4
EU - Europa 4
GA - Gabon 4
GT - Guatemala 4
HU - Ungheria 4
KZ - Kazakistan 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
KG - Kirghizistan 3
KH - Cambogia 3
MK - Macedonia 3
OM - Oman 3
SV - El Salvador 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GY - Guiana 2
LY - Libia 2
Totale 28.162
Città #
Ashburn 1.631
Singapore 1.289
Hong Kong 1.131
Fairfield 953
San Jose 844
Woodbridge 758
Santa Clara 726
Dallas 665
Houston 648
Ann Arbor 590
Serra 583
Chandler 529
Seattle 414
Shanghai 401
Sofia 364
Hefei 355
Cambridge 349
Wilmington 343
New York 335
Beijing 325
Boardman 278
Council Bluffs 267
Seoul 267
Milan 252
Los Angeles 225
Boulder 190
Jacksonville 184
Ottawa 179
Princeton 173
Lauterbourg 172
Lubumbashi 160
Lawrence 156
Ho Chi Minh City 149
Medford 136
London 134
Tokyo 120
Helsinki 115
Nanjing 105
Florence 104
Hanoi 96
Munich 95
São Paulo 95
Abidjan 94
Des Moines 88
Izmir 85
Buffalo 82
Vienna 82
Dearborn 78
Istanbul 76
Dong Ket 71
Pisa 67
Frankfurt am Main 66
Redondo Beach 58
Bern 56
San Diego 52
Atlanta 51
Turku 46
Rome 43
Nanchang 42
Orem 41
Lucca 37
Kunming 36
Washington 36
Jüchen 33
Warsaw 32
Belo Horizonte 31
Bremen 31
Lagos 31
Phoenix 30
Toronto 30
Nuremberg 28
Ogden 28
Shenyang 28
Brooklyn 27
Brussels 27
Rio de Janeiro 27
Chicago 26
Columbus 25
Montreal 25
Redwood City 25
Tashkent 25
Dakar 24
Haiphong 24
Casablanca 23
Changsha 21
Dhaka 21
San Francisco 21
Tianjin 21
Amsterdam 20
Baghdad 20
Boende 20
Chennai 20
Hyderabad 20
Da Nang 19
Norwalk 19
Paris 19
Campinas 18
Denver 18
Düsseldorf 18
Johannesburg 18
Totale 19.065
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 551
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 304
Management of Chronic constipation in general practice 269
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? 269
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 268
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy 261
Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights 256
Efficacy of Dupilumab for Induction and Maintenance of Remission in Patients With Eosinophilic Gastritis, Enteritis, and Colitis With Concomitant Eosinophilic Esophagitis 254
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 248
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 239
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 236
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 232
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 229
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 223
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 214
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole 208
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 207
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 202
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 201
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 200
Famotidine in the short-term treatment of duodenal ulcer and of concomitant peptic lesions : comparison with cimetidina 197
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 197
Low FODMAP diet: Evidence, doubts, and hopes 195
Irritable bowel syndrome and chronic constipation: Fact and fiction 194
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 194
Trauma quality indicators: internationally approved core factors for trauma management quality evaluation 194
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 193
Role of faecal calprotectin as non-invasive marker of intestinal inflammation 192
The general practitioner's approach to irritable bowel syndrome: from intention to practice 190
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 190
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 190
Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation 190
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 186
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 183
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 182
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 181
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 181
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 179
Refractory Gastroesophageal Reflux Disease: A Management Update 179
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 176
Radionuclide evaluation of the lower gastrointestinal tract 175
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 174
Liver triglyceride accumulation after chronic ethanol administration: a possible protective role of metadoxina and ubiquinon 172
Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management with Alverine Citrate/Simeticone 170
Alcohol and women: a study in high schools 169
Esophageal testing: What we have so far 168
The Diagnosis and Management of Chronic Constipation in Italy: Results from a Survey Conducted among Italian Gastroenterologists 165
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 165
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 165
Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study 164
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits 163
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio 163
Pelvic floor dyssynergia and psychiatric disorders. Does the snake bite its tail? 161
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study 161
Diets including Animal Food Are Associated with Gastroesophageal Reflux Disease 159
A new psychiatric assessment of patients affected with functional gastrointestinal diseases. 159
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 159
Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease 158
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts 158
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 158
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 158
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease 157
Evaluation of latent links between irritable bowel syndrome and sleep quality 157
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease 156
A low-FODMAP diet for irritable bowel syndrome: Some answers to the doubts from a long-term follow-up 156
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 156
Alterazioni della motilità colecistica nella distrofia miotonica: valutazione mediante ecotomografia funzionale 155
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 155
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations 155
Gastrointestinal manifestations in myotonic muscular dystrophy 154
Low fermentable oligo-di-and mono-saccharides and polyols (Fodmaps) or gluten free diet: What is best for irritable bowel syndrome? 154
Pelvic floor rehabilitation for defecation disorders 153
High Resolution and High Definition Anorectal Manometry 153
I farmaci citoprotettivi 151
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study 149
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 149
Serum gamma-glutamyl-transpeptidase isoforms in alcoholic liver disease 149
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 148
Difficult defecation in constipated patients: Diagnosis by minimally invasive diagnostic tests 147
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome 147
Is gluten the only culprit for non-celiac gluten/wheat sensitivity? 147
Gallbladder motility following intake of mineral bicarbonate-alkaline water. Ultrasonographic assessement 146
The genetics of human serotonin transporter and irritable bowel syndrome 146
Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications 144
Diagnosi e follow-up ecografici di un ematoma splenico 144
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 144
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 144
Fecal calprotectin: Current and future perspectives for inflammatory bowel disease treatment 144
Can psychiatric evaluation be useful in patients affected with pelvic floor dyssynergia? 143
Duloxetine in panic disorder with somatic gastric pain 143
Is a low FODMAP diet dangerous? 143
Gastric emptying in myotonic dystrophic patients. 142
Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS 140
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 140
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab 139
Different perception of chronic constipation between patients and gastroenterologists 139
Double pylorus: report of two cases and review of the literature 138
Plecanatide for the treatment of chronic idiopathic constipation in adult patients 138
The female pelvic floor through midlife and aging. 138
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 137
Totale 18.018
Categoria #
all - tutte 86.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.627 0 71 29 96 298 233 77 107 90 50 112 464
2022/20231.989 248 271 182 132 199 256 25 166 334 7 148 21
2023/20241.688 192 132 232 99 205 348 103 53 43 29 70 182
2024/20256.288 144 215 166 361 441 585 467 355 668 839 798 1.249
2025/20268.433 452 1.044 915 836 775 625 1.091 433 739 919 284 320
2026/20271.106 527 579 0 0 0 0 0 0 0 0 0 0
Totale 28.715